leisure time -WSS

leisure time

author：fashion 2025-09-30 21:58:23 - browse：71

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： STAT Summit: Ending the crisis of Black deaths in the U.S.

Wikipedia

hotspot

WSS

STAT Readout: Friday, Oct. 20 biotech updates

STAT Summit: Ending the crisis of Black deaths in the U.S.

UnitedHealth, Optum discontinue NaviHealth name

Florida babysitter arrested over hot car death, authorities say

What is the Turing Test that determines if computers can think?

STAT Readout Newsletter: Biotech news today

hotspot

leisure time

knowledge

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth, Optum discontinue NaviHealth name

United colonoscopy coverage change 'may cost lives,' doctors say

How Brent Saunders' Allergan experiment failed

Activists slam private health insurers over coverage restrictions

Smaller biotechs seek to piggyback on weight loss drug boom

Alkermes shareholders re

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Summit: How researchers deal with rejection

entertainment

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Roche drug slashes death risk in early

STAT Summit: Ending the crisis of Black deaths in the U.S.

New chief aims to remake Sanofi Genzyme

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Wikipedia

Wikipedia

hotspot

knowledge